May 19, 2016
Dr. Zeda Rosenberg, IPM’s chief executive officer, talks with Erin Houston of Devex at the Women Deliver 2016 conference about IPM’s public-private partnership model, promising HIV prevention products for women like IPM’s monthly dapivirine vaginal ring and next steps for the ring. Length: approximately 15 minutes
October 01, 2015
Women and girls continue to bear the burden of the HIV/AIDS epidemic, especially in sub-Saharan Africa. New tools in development called microbicides could give women self-initiated prevention methods.Learn about the only microbicide now in efficacy trials - IPM's monthly dapivirine vaginal ring - and how women could soon have new options to protect their sexual and reproductive health.Also available in Luganda, Sepedi, Tswana, Xhosa and Zulu. ...
March 02, 2015
Dr. Zeda Rosenberg, IPM’s chief executive officer, sits with Fred Schaich, president of the International Foundation for Alternative Research in AIDS (IFARA) to discuss promising developments in HIV prevention research for women in this video from the 2015 Conference on Retroviruses and Opportunistic Infections. Length: approximately 11 minutes
July 25, 2014
Dr. Zeda Rosenberg, IPM's chief executive officer, reflects on the 20th International AIDS Conference in this video from the AIDS 2014 Live digital hub. She highlights young women in sub-Saharan Africa as a key population and discusses the importance of women-initiated products like microbicides as HIV prevention tools. Length: approximately 2 minutes
Infographic: Top Three Reasons Why the Expanded IPM-Janssen Partnership is a Boost to Women's Health
In May 2014, IPM and Janssen R&D Ireland, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, expanded their longstanding collaboration for the development and delivery of sexual and reproductive health products containing the antiretroviral drug dapivirine. See the top reasons why this agreement is important for women.
March 08, 2013
Real Voices is an IPM video series featuring interviews with scientists, clinicians, advocates and community members, who share their views about the need for microbicides women can use to reduce their risk of HIV infection. This third video of the series highlights clinic researchers and outreach workers offering their reflections on the challenges women in their communities face and their hopes for the future.It is with these hopes in mind –...
August 14, 2010
IPM CEO Dr. Zeda Rosenberg spoke with SAfm Radio in South Africa on August 14, 2010, for its Science Matters program about the milestone findings from the CAPRISA 004 trial showing proof-of-concept for microbicides. In the interview, Dr. Rosenberg speaks about the future of microbicides in the wake of the promising results.Length: 22 minutesThanks to SAfm for a copy of the audio and permission to rebroadcast from our website.